During the past decade, Service de Médecine Interne conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Service de Médecine Interne" are "Autoimmune Hemolytic Anemia" (1 trials), "Immune Thrombocytopenia" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Service de Médecine Interne" in a lesser frequency.

Most popular intervention types in "Service de Médecine Interne" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BEVACIZUMAB" (1 trials) and "no specific intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service de Médecine Interne" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Service de Médecine Interne". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Service de Médecine Interne, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Service de Médecine Interne, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".